| Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy GH Nam, Y Choi, GB Kim, S Kim, SA Kim, IS Kim Advanced Materials 32 (51), 2002440, 2020 | 232 | 2020 |
| Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer GH Nam, EJ Lee, YK Kim, Y Hong, Y Choi, MJ Ryu, J Woo, Y Cho, DJ Ahn, ... Nature communications 9 (1), 2165, 2018 | 96 | 2018 |
| Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer GH Nam, M Kwon, H Jung, E Ko, SA Kim, Y Choi, SJ Song, S Kim, Y Lee, ... Journal for ImmunoTherapy of Cancer 9 (7), e002474, 2021 | 58 | 2021 |
| In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic … S Kim, SA Kim, GH Nam, Y Hong, GB Kim, Y Choi, S Lee, Y Cho, M Kwon, ... Journal for ImmunoTherapy of Cancer 9 (1), e001481, 2021 | 57 | 2021 |
| Functionalized exosome harboring bioactive molecules for cancer therapy YK Kim, Y Choi, GH Nam, IS Kim Cancer letters 489, 155-162, 2020 | 32 | 2020 |
| An optimized protocol to determine the engulfment of cancer cells by phagocytes using flow cytometry and fluorescence microscopy GH Nam, Y Hong, Y Choi, GB Kim, YK Kim, Y Yang, IS Kim Journal of Immunological Methods 470, 27-32, 2019 | 24 | 2019 |
| Small extracellular vesicles as a new class of medicines I Lee, Y Choi, DU Shin, M Kwon, S Kim, H Jung, GH Nam, M Kwon Pharmaceutics 15 (2), 325, 2023 | 14 | 2023 |
| Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy YK Kim, Y Hong, YR Bae, J Goo, SA Kim, Y Choi, GH Nam, M Kwon, ... Journal of Controlled Release 351, 727-738, 2022 | 14 | 2022 |
| Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity Y Choi, GH Nam, GB Kim, S Kim, YK Kim, SA Kim, HJ Kim, EJ Lee, IS Kim Cancer Gene Therapy 28 (9), 960-970, 2021 | 10 | 2021 |
| Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment Y Choi, SA Kim, H Jung, E Kim, YK Kim, S Kim, J Kim, Y Lee, MK Jo, ... Journal for ImmunoTherapy of Cancer 12 (7), e008864, 2024 | 2 | 2024 |
| Oral Cancer Immunotherapy through a Simvastatin‐Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity SA Kim, G Nam, YR Bae, SK Jha, S Kim, Y Choi, Y Lee, M Kwon, C Jeong, ... Advanced Therapeutics 4 (8), 2100025, 2021 | 2 | 2021 |
| TOP-351-YI A therapeutic strategy to target CD47 using SIRP alpha expressed extracellular vesicles derived fromengineered mesenchymal stem cells to promote liver regeneration … S Kim, Y Choi, GH Nam, IS Kim Journal of Hepatology 80, S104, 2024 | | 2024 |
| Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα extracellular vesicles for treating acute liver failure S Kim, YK Kim, S Kim, YS Choi, I Lee, H Joo, J Kim, M Kwon, S Park, ... bioRxiv, 2024.05. 24.592430, 2024 | | 2024 |
| 790 Paclitaxel can modulate the functional feature of tumor-associated macrophage and consequently enhance the efficacy of immunotherapy in triple-negative breast cancer S Kang, J Hong, H Jung, E Kim, Y Choi, GH Nam, M Kwon Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Immunogenic clearance sensitizes cold tumor to PD-1 blockade by enhancing quantity and quality of CD8+ T cells GH Nam, Y Choi, IS Kim Cancer Research 80 (16_Supplement), 3321-3321, 2020 | | 2020 |